Results 131 to 140 of about 19,360 (264)

Multi‐omics profiling of chronic immune‐mediated skin diseases: SKINERGY protocol and strategic evaluation

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
The SKINERGY study will investigate six immune‐mediated inflammatory skin diseases through a nationwide collaboration across all Dutch university medical centres. Involving 720 patients and 120 healthy volunteers, it is aimed at generating a high‐quality dataset to identify biomarkers that enable personalized treatment strategies and improved disease ...
N. G. Koster   +68 more
wiley   +1 more source

Expert panel perspectives on management of GERD post esophageal POEM: a national survey study. [PDF]

open access: yesSurg Endosc
Cricco-Lizza E   +6 more
europepmc   +1 more source

Ruxolitinib cream in adults with moderate atopic dermatitis after failure of other topicals: A randomized trial

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
In adults with moderate AD post‐TCS and ‐TCI, who may otherwise be eligible for systemic therapy, 1.5% ruxolitinib cream improved clinical signs and symptoms in the TRuE‐AD4 study. Abstract Background In patients with moderate atopic dermatitis (AD), topical corticosteroids (TCS) and topical calcineurin inhibitors (TCI) often do not sufficiently ...
José Manuel Carrascosa   +14 more
wiley   +1 more source

Patient treatment needs in atopic dermatitis: A real‐world cohort study

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
Among 697 adults with moderate‐to‐severe atopic dermatitis, itch relief was the leading treatment priority, whereas other needs differed by age, sex, education and disease onset. Patient‐reported outcomes tracked perceived benefit more closely than physician‐assessed severity, supporting systematic needs assessment to individualize care.
Kristina Ludemann   +33 more
wiley   +1 more source

Home - About - Disclaimer - Privacy